• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Serological investigation of racehorse vaccination against equine influenza in Morocco

tetano

Editor, Senior Moderator
Vet Microbiol. 2018 Sep;223:153-159. doi: 10.1016/j.vetmic.2018.08.014. Epub 2018 Aug 11.
[h=1]Serological investigation of racehorse vaccination against equine influenza in Morocco.[/h] Dilai M[SUP]1[/SUP], Piro M[SUP]2[/SUP], Fougerolle S[SUP]3[/SUP], El Harrak M[SUP]4[/SUP], Mahir W[SUP]5[/SUP], El Mourid R[SUP]5[/SUP], Legrand L[SUP]3[/SUP], Paillot R[SUP]3[/SUP], Fassi Fihri O[SUP]5[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] In order to evaluate the vaccination status against equine influenza (EI) in Moroccan racehorses, a serological investigation was carried out on 509 racehorses using three serological tests: an Enzyme-Linked Immunosorbent Assay (ELISA), the Hemagglutination Inhibition (HI) test and the Single Radial Haemolysis (SRH) assay. The serological analysis showed 56% of seropositivity by ELISA, 67% by HI and 89.4% by SRH (with 69.9% above the clinical protection threshold). Using the Kappa test, the SRH and HI assays showed a strong agreement, the SRH and ELISA assays had a moderate agreement and the HI and ELISA assays showed a poor agreement. Seropositivity was positively correlated with the age of horses and the number of immunisation received. EI vaccines used during the last immunisation before the study had a weak influence on the serological status. This effect was observed when the vaccines Calvenza and Fluvac Innovator? were used, with 94.1% and 100% of seropositivity when measured by HI, and with 100% and 94.7% exceeding the clinical protection threshold when measured by SRH, respectively. No effect was found when other EI vaccines, including Prequenza-Te? (67% coverage (342/509) and Proteqflu-Te? (22% coverage (114/509) were used; with 64% and 67.5% seropositivity (HI) and with 66.4% and 72.8% above the clinical threshold (SRH), respectively. The location and the time since last vaccination have no influence on the serological result. Overall, levels of protective antibody against EI in Moroccan racehorses remain a concern despite mandatory vaccination.


[h=4]KEYWORDS:[/h] ELISA; Equine influenza virus; HI; Morocco.; Racehorses; SRH; Vaccination

PMID: 30173741 DOI: 10.1016/j.vetmic.2018.08.014
 
Back
Top Bottom